Effects of erythropoietin on fibroblast growth factor 23 in mice and humans

BACKGROUND: Erythropoietin (EPO) has been reported as a novel determinant of fibroblast growth factor 23 (FGF23) production; however, it is unknown whether FGF23 is stimulated by chronic exposure to EPO or by EPO administration in nonpolycystic chronic kidney disease (CKD) models. METHODS: We analyz...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nephrol Dial Transplant
Main Authors: Hanudel, Mark R, Eisenga, Michele F, Rappaport, Maxime, Chua, Kristine, Qiao, Bo, Jung, Grace, Gabayan, Victoria, Gales, Barbara, Ramos, Georgina, de Jong, Maarten A, van Zanden, Jelmer J, de Borst, Martin H, Bakker, Stephan J L, Nemeth, Elizabeta, Salusky, Isidro B, Gaillard, Carlo A J M, Ganz, Tomas
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
ORIGINAL ARTICLES
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6888066/
https://ncbi.nlm.nih.gov/pubmed/30007314
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfy189
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados